Evidence map›Paper›PMID 38137551›Full record

ArticleBiomedicines2023

Clinical and Microbiological Impact of Implementing a Decision Support Algorithm through Microbiologic Rapid Diagnosis in Critically Ill Patients: An Epidemiological Retrospective Pre-/Post-Intervention Study.

Alejandro Rodríguez, Frederic Gómez, Carolina Sarvisé, Cristina Gutiérrez, Montserrat Galofre Giralt, María Dolores Guerrero-Torres, Sergio Pardo-Granell, Ester Picó-Plana, Clara Benavent-Bofill, Sandra Trefler and 10 more

Abstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alejandro RodríguezCritical Care Department, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, 43005 Tarragona, Spain.
Frederic GómezPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Carolina SarviséPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Cristina GutiérrezPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.ORCID 0000-0003-2626-1957
Montserrat Galofre GiraltPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
María Dolores Guerrero-TorresPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Sergio Pardo-GranellPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Ester Picó-PlanaPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Clara Benavent-BofillPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Sandra TreflerCritical Care Department, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, 43005 Tarragona, Spain.
Julen BerruetaCritical Care Department, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, 43005 Tarragona, Spain.ORCID 0009-0009-1015-9780
Laura CanadellFaculty of Medicine, Department of Basic Medical Sciences, Rovira & Virgili University, 43005 Tarragona, Spain.ORCID 0000-0003-3666-2332
Laura ClaveriasCritical Care Department, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, 43005 Tarragona, Spain.
Erika Esteve PitarchPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Montserrat OlonaPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Graciano García PardoPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
Xavier TeixidóICU Nursing, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain.
Laura BordonadoICU Nursing, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain.
María Teresa SansPere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.
María BodíCritical Care Department, Hospital Universitari de Tarragona Joan XXIII, Mallafre Guasch 4, 43005 Tarragona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData on the benefits of rapid microbiological testing on antimicrobial consumption (AC) and antimicrobial resistance patterns (ARPs) are scarce. We evaluated the impact of a protocol based on rapid techniques on AC and ARP in intensive care (ICU) patients.

methodsA retrospective pre- (2018) and post-intervention (2019-2021) study was conducted in ICU patients. A rapid diagnostic algorithm was applied starting in 2019 in patients with a lower respiratory tract infection. The incidence of nosocomial infections, ARPs, and AC as DDDs (defined daily doses) were monitored.

resultsA total of 3635 patients were included: 987 in the pre-intervention group and 2648 in the post-intervention group. The median age was 60 years, the sample was 64% male, and the average APACHE II and SOFA scores were 19 points and 3 points. The overall ICU mortality was 17.2% without any differences between the groups. An increase in the number of infections was observed in the post-intervention group (44.5% vs. 17.9%,

conclusionThe implementation of an algorithm based on rapid microbiological diagnostic techniques allowed for a significant reduction in AC and ARPs without affecting the prognosis of critically ill patients.

Indexed as

antimicrobial consumptiondefined daily doseFilmArraysnosocomial infectionrapid microbiological diagnostic techniquesventilator-associated pneumonia

Identifiers

PMID38137551
PMCPMC10741655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.